Evidence map›Paper›PMID 33802050›Full record

ArticleJournal of clinical medicine2021

Effects of Hyperbaric Oxygen Therapy in Children with Severe Atopic Dermatitis.

Judyta Mews, Agata Tomaszewska, Jacek Siewiera, Sławomir Lewicki, Karolina Kuczborska, Agnieszka Lipińska-Opałka, Bolesław Kalicki

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05427760 (Effect of Using Oxygen on the Diaper Dermatitis in Infants), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05427760 nacompletednot on this mapstarted 2022, after this paper: background citation

Effect of Using Oxygen on the Diaper Dermatitis in Infants

TypeinterventionalSponsorIstanbul University - CerrahpasaRan2022 to 2023Enrolled103ConditionsDiaper Rash, Diaper DermatitisArmsOxygen
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Judyta MewsDepartment of Pediatrics, Nephrology and Allergology, Military Institute of Medicine, Szaserów 128 Str., 04-141 Warsaw, Poland.ORCID 0000-0002-4887-1951
Agata TomaszewskaDepartment of Pediatrics, Nephrology and Allergology, Military Institute of Medicine, Szaserów 128 Str., 04-141 Warsaw, Poland.
Jacek SiewieraClinical Department of Hyperbaric Medicine, Military Institute of Medicine, 04-141 Warsaw, Poland.
Sławomir LewickiDepartment of Regenerative Medicine and Cell Biology, Military Institute of Hygiene and Epidemiology, 04-141 Warsaw, Poland.ORCID 0000-0002-0539-0680
Karolina KuczborskaDepartment of Pediatrics, Nephrology and Allergology, Military Institute of Medicine, Szaserów 128 Str., 04-141 Warsaw, Poland.
Agnieszka Lipińska-OpałkaDepartment of Pediatrics, Nephrology and Allergology, Military Institute of Medicine, Szaserów 128 Str., 04-141 Warsaw, Poland.
Bolesław KalickiDepartment of Pediatrics, Nephrology and Allergology, Military Institute of Medicine, Szaserów 128 Str., 04-141 Warsaw, Poland.ORCID 0000-0003-1606-5100
Wojskowy Instytut Medycyny Lotniczej · PLKazimierz Pułaski University of Technology and Humanities in Radom · PL

Funding

Military Institute of Medicine 527/2018
6 · The paper itself

Abstract

In the course of atopic dermatitis (AD), the overactivity of the immune system, associated with predominant Th2 lymphocyte responses, is observed, which leads to an increased inflammatory reaction. Cases of a severe course of atopic dermatitis lead to the search for new therapeutic options. The aim of this study was to assess the effects of hyperbaric oxygen therapy (HBOT) treatment for severe cases of AD in children. A total of 15 children with severe AD underwent therapy. The influence of HBOT on the clinical course of AD and immunomodulatory effect of the therapy was analyzed by the SCORAD and objective SCORAD (oSCORAD) scales and by determining the serum concentration of immunological parameters (blood: nTreg lymphocytes, CD4+CD25highCD127-FOXP3+, NKT lymphocytes CD3+, CD16/56+, and serum: total IgE, cytokines IL-4, IL-6, and IL-10, before and after the 30-day treatment cycle). The study showed a significant effect of the therapy on the improvement of the skin condition. In all children, a reduction in the extent and intensity of skin lesions, reduction of redness, swelling, oozing/crusting, scratch marks and skin lichenification after HBOT was observed. Patients also reported a reduction in the intensity of pruritus and an improvement in sleep quality after therapy. In all children, a statistically significant decrease in the serum level of IgE was observed. However, no statistically significant changes in the blood levels of IL-4, IL-6 and IL-10, as well as the percentage of CD4

Indexed as

atopic dermatitischildrenhyperbaric chamberimmune systemSCORAD

Identifiers

PMID33802050
PMCPMC8001365
OpenAlexW3133518269

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.